It is time to change US trade policy to foster access to medicines

Category: Legal
Visits: 71 total, 1 today
Keywords: access to medicines, biosimilars, generic drugs, trade agreements, USMCA

While Americans are deeply concerned about drug prices, the United States Trade Representative (USTR) continues to negotiate agreements like the United States-Mexico-Canada Agreement (USMCA) that put at risk the sustainability of the generic industry and undermine the development of biosimilars that play a critical role in access to medicines. It is time to restore some balance to US trade policy.

Subscribe now to GaBI Journal to view full information of this article to be published in the next journal issue.

Go Back Print

Leave a Reply